Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer’s Disease

- NICE Commit to Reviewing Existing Guidance 'As Soon As Possible' LONDON, July 1/PRNewswire/ -- On June 11, the National Institute for Health and Clinical Excellence (NICE) announced that, following consultation with stakeholders on the economic... (Source: Drugs.com - Pharma News)

Read the original Alzheimer's Group Resources article at MedWorm: Alzheimer's ...

Leave a Reply